Novartis AG (NVS) Receives $80.42 Average Target Price from Analysts

Novartis AG (NYSE:NVS) has been assigned an average recommendation of “Hold” from the nineteen research firms that are currently covering the company. Two investment analysts have rated the stock with a sell recommendation, eleven have given a hold recommendation and six have issued a buy recommendation on the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $80.42.

A number of research firms recently issued reports on NVS. JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Novartis AG in a research report on Tuesday. Vetr cut shares of Novartis AG from a “strong-buy” rating to a “buy” rating and set a $78.32 price objective for the company. in a research report on Thursday, April 6th. Cowen and Company cut shares of Novartis AG from an “outperform” rating to a “market perform” rating and decreased their price target for the company from $87.00 to $77.00 in a research report on Wednesday, April 5th. Goldman Sachs Group Inc restated a “neutral” rating on shares of Novartis AG in a research report on Wednesday, March 22nd. Finally, Liberum Capital assumed coverage on shares of Novartis AG in a research report on Thursday, March 9th. They issued a “buy” rating for the company.

A number of institutional investors have recently modified their holdings of the company. Howe & Rusling Inc. raised its position in shares of Novartis AG by 192.2% in the first quarter. Howe & Rusling Inc. now owns 1,341 shares of the company’s stock worth $100,000 after buying an additional 882 shares in the last quarter. Sowell Financial Services LLC acquired a new position in shares of Novartis AG during the fourth quarter worth $116,000. Zions Bancorporation raised its position in shares of Novartis AG by 21.0% in the fourth quarter. Zions Bancorporation now owns 1,656 shares of the company’s stock worth $120,000 after buying an additional 287 shares in the last quarter. Mosaic Family Wealth LLC raised its position in shares of Novartis AG by 11.2% in the third quarter. Mosaic Family Wealth LLC now owns 1,886 shares of the company’s stock worth $149,000 after buying an additional 190 shares in the last quarter. Finally, Integrated Wealth Counsel LLC raised its position in shares of Novartis AG by 13.8% in the third quarter. Integrated Wealth Counsel LLC now owns 1,998 shares of the company’s stock worth $158,000 after buying an additional 242 shares in the last quarter. Hedge funds and other institutional investors own 9.82% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Novartis AG (NVS) Receives $80.42 Average Target Price from Analysts” was reported by Markets Daily and is the property of of Markets Daily. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international copyright law. The original version of this news story can be accessed at https://www.themarketsdaily.com/2017/04/21/novartis-ag-nvs-receives-80-42-average-target-price-from-analysts.html.

Shares of Novartis AG (NYSE:NVS) traded down 0.30% on Tuesday, hitting $73.40. 2,326,290 shares of the stock were exchanged. Novartis AG has a one year low of $66.93 and a one year high of $83.58. The firm has a market capitalization of $174.26 billion, a PE ratio of 26.21 and a beta of 0.73. The company has a 50-day moving average price of $74.50 and a 200-day moving average price of $73.40.

Novartis AG (NYSE:NVS) last released its quarterly earnings data on Wednesday, January 25th. The company reported $1.12 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $1.12. The business earned $12.32 billion during the quarter, compared to analysts’ expectations of $12.44 billion. Novartis AG had a net margin of 13.80% and a return on equity of 15.37%. The firm’s quarterly revenue was down 1.6% compared to the same quarter last year. During the same period in the prior year, the company earned $1.14 EPS. Equities research analysts expect that Novartis AG will post $4.69 earnings per share for the current year.

Novartis AG Company Profile

Novartis AG is a holding company, which provides healthcare solutions. The Company is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. The Company’s segments include Innovative Medicines, Sandoz, Alcon and Corporate activities.

5 Day Chart for NYSE:NVS

Receive News & Ratings for Novartis AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novartis AG and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply